These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 4522072

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
    Neumeyer D, Anschel R, Eule H, Fichtner K, Ganguin HG, Pickroth G.
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):135-8. PubMed ID: 4491710
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C, Sibila S.
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) I. Clinical course].
    Horsfall PA.
    Bull Int Union Tuberc; 1974; 49(1):447-51. PubMed ID: 4619566
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Acute renal failure during daily rifampicin treatment].
    Alvestrand A, Asaba H, Boman G, Nilsson BS.
    Lakartidningen; 1977 Jan 26; 74(4):230-1. PubMed ID: 834090
    [No Abstract] [Full Text] [Related]

  • 37. [Comparative clinical evaluation of the treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin by the daily and intermittent methods].
    Zierski M, Bek E, Bergson H, Kucharska A, Strupczewska-Janusz H.
    Pneumonol Pol; 1977 Apr 26; 45(4):277-90. PubMed ID: 854460
    [No Abstract] [Full Text] [Related]

  • 38. [Systemic collateral effects of intermittent antituberculous treatments with rifampicin].
    Decroix G, Pujet JC.
    Rev Tuberc Pneumol (Paris); 1971 Nov 26; 35(7):733-43. PubMed ID: 5151216
    [No Abstract] [Full Text] [Related]

  • 39. [Effectiveness of rifampin and ethambutol in the treatment of pulmonary tuberculosis].
    Gol'dshteĭn VD, Prokhorov EP.
    Probl Tuberk; 1973 Nov 26; 51(12):36-40. PubMed ID: 4782101
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.